Nektar Therapeutics (NKTR) Receivables - Net: 2010-2025
Historic Receivables - Net for Nektar Therapeutics (NKTR) over the last 13 years, with Sep 2025 value amounting to $200,000.
- Nektar Therapeutics' Receivables - Net was N/A to $200,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $200,000, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2023, which is 79.85% down from last year.
- Per Nektar Therapeutics' latest filing, its Receivables - Net stood at $200,000 for Q3 2025, which was down 83.28% from $1.2 million recorded in Q2 2024.
- Nektar Therapeutics' Receivables - Net's 5-year high stood at $30.2 million during Q1 2022, with a 5-year trough of $200,000 in Q3 2025.
- Its 3-year average for Receivables - Net is $1.8 million, with a median of $1.3 million in 2023.
- Per our database at Business Quant, Nektar Therapeutics' Receivables - Net crashed by 90.09% in 2023 and then grew by 20.77% in 2024.
- Nektar Therapeutics' Receivables - Net (Quarterly) stood at $22.5 million in 2021, then plummeted by 73.41% to $6.0 million in 2022, then slumped by 79.85% to $1.2 million in 2023, then fell by 10.41% to $1.2 million in 2024, then reached $200,000 in 2025.
- Its Receivables - Net was $200,000 in Q3 2025, compared to $1.2 million in Q2 2024 and $3.6 million in Q1 2024.